COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,574,532 | -38.1% | 2,829,712 | 0.0% | 2.21% | -19.1% |
| Q2 2023 | $8,998,484 | -2.8% | 2,829,712 | 0.0% | 2.73% | +11.2% |
| Q1 2023 | $9,253,158 | -35.0% | 2,829,712 | 0.0% | 2.46% | -35.2% |
| Q4 2022 | $14,233,452 | +120.6% | 2,829,712 | 0.0% | 3.79% | +118.5% |
| Q3 2022 | $6,452,000 | -14.0% | 2,829,712 | 0.0% | 1.74% | -39.4% |
| Q2 2022 | $7,499,000 | +93.4% | 2,829,712 | 0.0% | 2.86% | +73.7% |
| Q1 2022 | $3,877,000 | -59.6% | 2,829,712 | -6.4% | 1.65% | -48.2% |
| Q4 2021 | $9,585,000 | – | 3,023,692 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 914,630 | $2,908,523 | 3.52% |
| Foresite Capital Management V, LLC | 1,324,071 | $4,210,546 | 3.08% |
| CHI Advisors LLC | 2,829,712 | $8,998,484 | 2.73% |
| Monashee Investment Management LLC | 1,969,296 | $6,262,361 | 1.50% |
| Orbimed Advisors | 22,362,850 | $71,113,863 | 1.29% |
| Prosight Management, LP | 2,167,994 | $6,894,220 | 1.03% |
| Vivo Capital, LLC | 3,556,023 | $11,308,153 | 0.78% |
| BRAIDWELL LP | 5,954,273 | $18,934,588 | 0.62% |
| Rock Springs Capital Management LP | 5,513,788 | $17,533,846 | 0.42% |
| CAXTON CORP | 43,466 | $138,220 | 0.40% |